Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Merck gains rights to Hansoh’s preclinical GLP-1 candidate in deal worth $2bn

The company will evaluate the asset’s potential to provide cardiometabolic benefits beyond weight reduction

- PMLiVE

Amgen’s Blincyto granted MHRA approval for new acute lymphoblastic leukaemia indication

Approximately 300 new adult cases of the blood cancer are diagnosed in the UK every year

- PMLiVE

FDA approves Organon’s Vtama cream to treat atopic dermatitis in adults and children

More than 26 million people in the US are affected by the inflammatory skin disease

- PMLiVE

Rare vs common diseases: key differences in educational approaches

By Lisa Parker

- PMLiVE

Communicating AI in healthcare: a guide for effective strategy

By Sean Walker

- PMLiVE

Big hats, no cattle

You get what you like, not what you need

- PMLiVE

Pro bono work in pharma

Making a difference beyond the bottom line

Investors in People Platinum logo

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy + Cuttsy

- PMLiVE

AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition

The deal includes an IL23R inhibitor in preclinical development for psoriasis and inflammatory bowel disease

- PMLiVE

GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe

- PMLiVE

Eli Lilly’s Omvoh recommended by CHMP to treat Crohn’s disease in adults

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease

- PMLiVE

Is omnichannel right for rare diseases?

By Emma Warnants and Chloe Zentai

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links